10X Genomics

10X Genomics

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$150,667
$151,036
$150,843
$166,030
Gross Profit
112,927
112,497
106,178
113,045
EBITDA
-8,972
-8,981
-937
63,537
EBIT
-18,476
-18,645
-12,847
51,437
Net Income
-19,425
-17,931
-13,470
-16,252
Net Change In Cash
150,667
151,036
150,843
166,030
Free Cash Flow
14,862
15,386
24,523
39,000
Cash
526,187
502,512
490,285
473,966
Basic Shares
130,805
129,984
128,291
127,078

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$642,823
$610,785
$618,727
$516,409
Gross Profit
443,881
414,482
409,313
396,023
EBITDA
3,909
-133,988
-205,111
-128,489
EBIT
-39,907
-177,696
-248,730
-161,495
Net Income
-43,544
-182,627
-255,099
-166,000
Net Change In Cash
642,823
610,785
618,727
516,409
Cost of Revenue
-368,676
Free Cash Flow
130,115
-5,729
-64,721
-165,267
Cash
473,966
344,067
359,284
219,746
Basic Shares
124,749
120,451
117,165
113,858

Earnings Calls

QuarterEPS
2026-09-30
-$0.15
2026-06-30
-$0.14
2026-03-31
$0.07
2025-12-31
$0.07